Typically, ARID1A loss is indicative of endometrioid-origin cancers; ARID1A mutations are found in 40% of endometrial cancers [27], 32% of endometrioid OCs, 29% of clear-cell OCs, and only 3% of HGSOC cases [28]. This evidence concerns the gene ARID1A and endometrial cancer.